About Intrexon Corp
Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. Its technologies combine the principles of precision engineering, statistical modeling, automation and production at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing, or LEAP, and ActoBiotics platform.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Exchange: NYSE
- Symbol: XON
- Previous Close: $21.91
- 50 Day Moving Average: $22.87
- 200 Day Moving Average: $26.55
- 52-Week Range: $118,575,000.00 - $20.39
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -30.01
- P/E Growth: 0.33
- Market Cap: $2.60B
- Outstanding Shares: 118,575,000
- Beta: 1.5
- Net Margins: -93.97%
- Return on Equity: -18.46%
- Return on Assets: -12.13%
Companies Related to Intrexon Corp:
- Debt-to-Equity Ratio: 0.01%
- Current Ratio: 3.15%
- Quick Ratio: 2.93%
What is Intrexon Corp's stock symbol?
Intrexon Corp trades on the New York Stock Exchange (NYSE) under the ticker symbol "XON."
Where is Intrexon Corp's stock going? Where will Intrexon Corp's stock price be in 2017?
8 brokers have issued 12-month target prices for Intrexon Corp's shares. Their forecasts range from $29.00 to $57.00. On average, they anticipate Intrexon Corp's share price to reach $44.43 in the next year.
When will Intrexon Corp announce their earnings?
Intrexon Corp is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.
Who owns Intrexon Corp stock?
Intrexon Corp's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Third Security LLC (52.43%), FMR LLC (5.45%), Iridian Asset Management LLC CT (3.17%), State Street Corp (1.70%), Frontier Capital Management Co. LLC (0.52%) and Michael & Susan Dell Foundation (0.37%). Company insiders that own Intrexon Corp stock include Fred Hassan, Joel D Liffman, Nir Nimrodi, Randal J Kirk and Suma Krishnan.
Who sold Intrexon Corp stock? Who is selling Intrexon Corp stock?
Intrexon Corp's stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, FMR LLC, State Street Corp, Iridian Asset Management LLC CT, Brown Advisory Inc., Guggenheim Capital LLC, Palo Alto Investors LLC and Private Advisor Group LLC.
Who bought Intrexon Corp stock? Who is buying Intrexon Corp stock?
Intrexon Corp's stock was bought by a variety of institutional investors in the last quarter, including Third Security LLC, Frontier Capital Management Co. LLC, Michael & Susan Dell Foundation, Clough Capital Partners L P, Dimensional Fund Advisors LP, A.R.T. Advisors LLC, Seven Eight Capital LP and Pacad Investment Ltd.. Company insiders that have bought Intrexon Corp stock in the last two years include Fred Hassan, Joel D Liffman, Nir Nimrodi and Randal J Kirk.
How do I buy Intrexon Corp stock?
Shares of Intrexon Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Intrexon Corp stock cost?
One share of Intrexon Corp stock can currently be purchased for approximately $21.91.